Key facts
- Rare Disease Data Trust’s last known valuation is $2.5M (Mar 2020).
- It has raised $1.3M across 1 recorded rounds; the latest was Seed Round ($751K) in Apr 2024.
- Notable investors include GrowthX Capital.
- Rare Disease Data Trust has filed 6 Form Ds with the SEC since 2020, most recently May 2024 ($154K sold to 1 investors).
- Status: Privately Held (backing).
Investors
1- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Rare Disease Data Trust
Funding rounds
1 roundsAbout Rare Disease Data Trust
Operator of a patient advocacy platform intended to diagnose rare diseases. The company's platform offers a service to connect biopharma companies with healthcare providers who have patients with rare diseases, enabling patients with rare diseases to get proper diagnosis and treatment.
- Sector
- Healthcare
- HQ
- Brentwood, TN, United States
- Founded
- 2020
- Website
- finding-rare.com/
- Ownership
- Privately Held (backing)
Rare Disease Data Trust doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Rare Disease Data Trust shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Rare Disease Data Trust in its N-PORT filings yet. We sweep new filings monthly.